BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 22709328)

  • 1. "My funky genetics": BRCA1/2 mutation carriers' understanding of genetic inheritance and reproductive merger in the context of new reprogenetic technologies.
    Werner-Lin A; Rubin LR; Doyle M; Stern R; Savin K; Hurley K; Sagi M
    Fam Syst Health; 2012 Jun; 30(2):166-80. PubMed ID: 22709328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decision-making on preimplantation genetic diagnosis and prenatal diagnosis: a challenge for couples with hereditary breast and ovarian cancer.
    Derks-Smeets IA; Gietel-Habets JJ; Tibben A; Tjan-Heijnen VC; Meijer-Hoogeveen M; Geraedts JP; van Golde R; Gomez-Garcia E; van den Bogaart E; van Hooijdonk M; de Die-Smulders CE; van Osch LA
    Hum Reprod; 2014 May; 29(5):1103-12. PubMed ID: 24603131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Awareness and attitude regarding reproductive options of persons carrying a BRCA mutation and their partners.
    Gietel-Habets JJ; de Die-Smulders CE; Derks-Smeets IA; Tibben A; Tjan-Heijnen VC; van Golde R; Gomez-Garcia E; Kets CM; van Osch LA
    Hum Reprod; 2017 Mar; 32(3):588-597. PubMed ID: 28073972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opinion about reproductive decision making among individuals undergoing BRCA1/2 genetic testing in a multicentre Spanish cohort.
    Fortuny D; Balmaña J; Graña B; Torres A; Ramón y Cajal T; Darder E; Gadea N; Velasco A; López C; Sanz J; Alonso C; Brunet J
    Hum Reprod; 2009 Apr; 24(4):1000-6. PubMed ID: 19112076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decisions and ethical issues among BRCA carriers and the use of preimplantation genetic diagnosis.
    Quinn GP; Vadaparampil ST; Bower B; Friedman S; Keefe DL
    Minerva Med; 2009 Oct; 100(5):371-83. PubMed ID: 19910890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer risk reduction and reproductive concerns in female BRCA1/2 mutation carriers.
    Staton AD; Kurian AW; Cobb K; Mills MA; Ford JM
    Fam Cancer; 2008; 7(2):179-86. PubMed ID: 18026853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of decision aids for female BRCA1 and BRCA2 mutation carriers: a systematic review.
    Krassuski L; Vennedey V; Stock S; Kautz-Freimuth S
    BMC Med Inform Decis Mak; 2019 Aug; 19(1):154. PubMed ID: 31370837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reproductive Decision-Making in Women with BRCA1/2 Mutations.
    Chan JL; Johnson LNC; Sammel MD; DiGiovanni L; Voong C; Domchek SM; Gracia CR
    J Genet Couns; 2017 Jun; 26(3):594-603. PubMed ID: 27796678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes.
    Berry DA; Iversen ES; Gudbjartsson DF; Hiller EH; Garber JE; Peshkin BN; Lerman C; Watson P; Lynch HT; Hilsenbeck SG; Rubinstein WS; Hughes KS; Parmigiani G
    J Clin Oncol; 2002 Jun; 20(11):2701-12. PubMed ID: 12039933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Family planning in carriers of BRCA1 and BRCA2 pathogenic variants.
    Haddad JM; Robison K; Beffa L; Laprise J; ScaliaWilbur J; Raker CA; Clark MA; Hofstatter E; Dalela D; Brown A; Bradford L; Toland M; Stuckey A
    J Genet Couns; 2021 Dec; 30(6):1570-1581. PubMed ID: 33904624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hereditary breast and ovarian cancer and reproduction: an observational study on the suitability of preimplantation genetic diagnosis for both asymptomatic carriers and breast cancer survivors.
    Derks-Smeets IA; de Die-Smulders CE; Mackens S; van Golde R; Paulussen AD; Dreesen J; Tournaye H; Verdyck P; Tjan-Heijnen VC; Meijer-Hoogeveen M; De Greve J; Geraedts J; De Rycke M; Bonduelle M; Verpoest WM
    Breast Cancer Res Treat; 2014 Jun; 145(3):673-81. PubMed ID: 24748567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Much more than a gene: hereditary breast and ovarian cancer, reproductive choices and family life.
    Dekeuwer C; Bateman S
    Med Health Care Philos; 2013 May; 16(2):231-44. PubMed ID: 22048863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.
    Domchek SM; Friebel TM; Singer CF; Evans DG; Lynch HT; Isaacs C; Garber JE; Neuhausen SL; Matloff E; Eeles R; Pichert G; Van t'veer L; Tung N; Weitzel JN; Couch FJ; Rubinstein WS; Ganz PA; Daly MB; Olopade OI; Tomlinson G; Schildkraut J; Blum JL; Rebbeck TR
    JAMA; 2010 Sep; 304(9):967-75. PubMed ID: 20810374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population-based screening for breast and ovarian cancer risk due to BRCA1 and BRCA2.
    Gabai-Kapara E; Lahad A; Kaufman B; Friedman E; Segev S; Renbaum P; Beeri R; Gal M; Grinshpun-Cohen J; Djemal K; Mandell JB; Lee MK; Beller U; Catane R; King MC; Levy-Lahad E
    Proc Natl Acad Sci U S A; 2014 Sep; 111(39):14205-10. PubMed ID: 25192939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attitudes to reproductive genetic testing in women who had a positive BRCA test before having children: a qualitative analysis.
    Ormondroyd E; Donnelly L; Moynihan C; Savona C; Bancroft E; Evans DG; Eeles R; Lavery S; Watson M
    Eur J Hum Genet; 2012 Jan; 20(1):4-10. PubMed ID: 21811309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations.
    Casey MJ; Synder C; Bewtra C; Narod SA; Watson P; Lynch HT
    Gynecol Oncol; 2005 May; 97(2):457-67. PubMed ID: 15863145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: US Preventive Services Task Force Recommendation Statement.
    ; Owens DK; Davidson KW; Krist AH; Barry MJ; Cabana M; Caughey AB; Doubeni CA; Epling JW; Kubik M; Landefeld CS; Mangione CM; Pbert L; Silverstein M; Simon MA; Tseng CW; Wong JB
    JAMA; 2019 Aug; 322(7):652-665. PubMed ID: 31429903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incorporating information regarding preimplantation genetic diagnosis into discussions concerning testing and risk management for BRCA1/2 mutations: a qualitative study of patient preferences.
    Hurley K; Rubin LR; Werner-Lin A; Sagi M; Kemel Y; Stern R; Phillips A; Cholst I; Kauff N; Offit K
    Cancer; 2012 Dec; 118(24):6270-7. PubMed ID: 22736296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Views of BRCA gene mutation carriers on preimplantation genetic diagnosis as a reproductive option for hereditary breast and ovarian cancer.
    Menon U; Harper J; Sharma A; Fraser L; Burnell M; ElMasry K; Rodeck C; Jacobs I
    Hum Reprod; 2007 Jun; 22(6):1573-7. PubMed ID: 17428877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation Carriers.
    Kuchenbaecker KB; McGuffog L; Barrowdale D; Lee A; Soucy P; Dennis J; Domchek SM; Robson M; Spurdle AB; Ramus SJ; Mavaddat N; Terry MB; Neuhausen SL; Schmutzler RK; Simard J; Pharoah PDP; Offit K; Couch FJ; Chenevix-Trench G; Easton DF; Antoniou AC
    J Natl Cancer Inst; 2017 Jul; 109(7):. PubMed ID: 28376175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.